Pharmaceutical

Filter

Current filters:

None

Popular Filters

6720 to 6744 of 7217 results

EMA boosts EU transparency with on-line publication of suspected side effect reports

31-05-2012

The European Medicines Agency yesterday began publishing suspected side effect reports for medicines…

BiotechnologyEuropePharmaceuticalRegulation

NZ's PHARMAC consults on funding for Iressa and Tarceva

31-05-2012

The Pharmaceutical Management Agency of New Zealand, PHARMAC, is seeking feedback on a proposal to:

Asia-PacificAstraZenecaIressaOncologyPharmaceuticalPricingRegulationRocheTarceva

Russia's colorectal cancer drug market to reach over $480 million in 2016

31-05-2012

The colorectal cancer (CRC) drug market in Russia will grow 3% annually to $487 million in 2016, according…

EuropeMarkets & MarketingOncologyPharmaceutical

AEterna Zentaris' perifosine seen as potential novel approach for mesothelioma

31-05-2012

Canada-based AEterna Zentaris (TSX: AEZ) has highlighted an article published in the May 2012 issue of…

AEterna ZentarisOncologyperifosinePharmaceuticalResearch

Pharma marketing investment in Brazil and China grows but declines in Russia

31-05-2012

Both Brazil and China showed marked increases in pharmaceutical marketing investments for 2011, despite…

Asia-PacificEuropeFinancialMarkets & MarketingPharmaceuticalSouth America

UCB buys majority stake in local drugmaker to expand in Brazil

31-05-2012

Belgium's leading pharma company UCB (Euronext Brussels: UCB) says it has signed an agreement to acquire…

GenericsMeizler BiopharmaMergers & AcquisitionsPharmaceuticalSouth AmericaUCB

Milestone payment for Ardea from Bayer, which executes license with Dyax

31-05-2012

AstraZeneca (The Pharma Letter April 23), said yesterday that it has earned a $7.5 million milestone…

Ardea BiosciencesBAY 86-9766BayerDyax CorpFinancialLicensingOncologyPharmaceuticalResearch

Expanded Access Program for enzalutamide agreed with US FDA

30-05-2012

The US Food and Drug Administration agreed that Medivation (Nasdaq: MDVN) and Japanese drug major Astellas…

Astellas PharmaBiotechnologyenzalutamideMDV3100MedivationNorth AmericaOncologyPharmaceuticalRegulation

US legislation could block public access to drug safety information, claim consumer groups

30-05-2012

A provision in the Food and Drug Administration Reform Act that would block public access to potentially…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Diabetes drug shows promise for traumatic brain injury

30-05-2012

Although the death toll is relatively low for people who suffer from traumatic brain injury (TBI), it…

Diabetesexendin-4NeurologicalPharmaceuticalResearch

Japan High Court rules in favor of AstraZeneca over Iressa deaths

30-05-2012

Anglo-Swedish drug major AstraZeneca's (LSE: AZN) Japanese subsidiary has received a decision from the…

Asia-PacificAstraZenecaIressaLegalOncologyPharmaceutical

Vertex slumps as firm revises Kalydeco data

30-05-2012

The USA's Vertex Pharmaceuticals (Nasdaq: VRTX) saw its shares plunge 19% to $52.85 in early trading…

KalydecoPharmaceuticalRare diseasesResearchRespiratory and PulmonaryVertex

Common painkillers such as aspirin may protect against skin cancer

29-05-2012

A new study suggests that aspirin and other similar painkillers may help protect against skin cancer.…

OncologyPharmaceuticalResearch

Problems facing Indonesia's pharma sector

29-05-2012

Environmentally, Indonesia is particularly prone to natural disasters, as the recent earthquakes, tsunamis…

Asia-PacificGenericsMarkets & MarketingPatentsPharmaceuticalPricing

Bristol-Myers sets up global accord with academia for immune-oncology

29-05-2012

US drug major Bristol-Myers Squibb (NYSE: BMY) yesterday announced the formation of the International…

Bristol-Myers SquibbOncologyPharmaceuticalResearch

New study reinforces the differentiating benefits of AstraZeneca's Crestor

29-05-2012

Data presented yesterday at the 2012 European Atherosclerosis Society (EAS) Congress in Milan, Italy,…

AstraZenecaCardio-vascularCrestorPharmaceuticalResearch

Ranbaxy gains US FDA approval for Absorica

29-05-2012

India's largest drugmaker Ranbaxy Laboratories (AB: BO) has received approval from the US Food and Drug…

AbsoricaCipher PharmaceuticalsDermatologicalsIsotretinoinNorth AmericaPharmaceuticalRanbaxy LaboratoriesRegulation

Meiji Seika to expand in Russian pharmaceutical market

29-05-2012

Japanese drugmaker Meiji Seika Pharma has signed a partnership agreement with R-Pharm, one of Russia's…

Antibiotics and Infectious diseasesEuropeLicensingMarkets & MarketingMeiji Seika PharmaPharmaceuticalR-Pharma

6720 to 6744 of 7217 results

COMPANY SPOTLIGHT

Menarini

Back to top